EndoVantage is Selected as a Finalist for the 2017 Chuck Hahn Emerging Enterprise Award

August 31, 2017

EndoVantage is chosen from 15 nominees to be one of three finalists for the 21st annual W.P Carey School of Business Spirit of Enterprise Awards. Read More

EndoVantage CMO Dr. Chong Presents Clinical Validation of the EndoVantage Technology at the SNIS Conference.

July 25, 2016

Chong B, Babiker H, Kalani Y, Baccin C, Mortensen M, Levitt M, McDougall C, Frakes D, and Albuquerque F. Predicting Flow Diverter Deployments and Clinical Validation. Society of NeuroInterventional Surgery 13th Annual Meeting. Poster. Abstract.

EndoVantage CTO Dr. Babiker Presents Clinical Validation of the EndoVantage Technology at the 2016 BMES/FDA Conference.

May 25, 2016

Babiker H, Kalani Y, Levitt M, McDougall C, Baccin C, Chong B, Frakes D, Albuquerque F. Clinical Validations of Simulated Neurovascular Braided Stent Deployments. BMES/FDA Frontiers in Medical Devices Conference Innovations in Modeling and Simulation: Patient-Centered Healthcare. Read More.

EndoVantage Wins IEEE Startup of the Year Award
Feb 13, 2016
EndoVantage receives the Startup of the Year Award at the 2016 Institute of Electrical and Electronics Engineers (IEEE) banquet in Phoenix, AZ.

Nair et al. Publish Scientific Work Using the EndoVantage Technology
Jan 27, 2016
Nair P,  Chong B, Indahlastari , Ryan J, Workman C, Babiker M, Farsani H, Baccin C, Frakes, D.  Hemodynamic Characterization of Geometric Cerebral Aneurysm Templates Treated With Embolic Coils. Journal of Biomechanical Engineering. Read More

Dr. Kalani Presents the EndoVantage Technology at the SNIS Conference
July 1, 2015
Kalani Y, Babiker H, Levitt M, McDougall C, Chong B, Frakes D, Albuquerque F. P-030 high fidelity simulations of endovascular cerebral aneurysm treatments. Society of NeuroInterventional Surgery. Read more.

EndoVantage’s Technology Featured in the Phoenix Business Journal
June, 2015
EndoVantage’s disruptive technology is highlighted in the Phoenix Business Journal’s “Health Care of the Future” segment. Read more.

Dr. Babiker Presents the EndoVantage Technology at the BMES/FDA Conference
May 8, 2015
Babiker M, Chong B, Kalani Y , Albuquerque F , Frakes D.  Patient-Based Finite Element Medical Device Evaluation Tools. BMES/FDA Frontiers in Medical Devices Conference: Innovations in Modeling and Simulation. Read More

Dr. Chong Presents the EndoVantage Technology  at the ABC-WIN Seminar
Jan 18, 2015
Dr. Brian Chong gives a presentation titled ‘Presurgical Planning: Adding Science to the Art’ at the Anatomy-Biology-Clinical Correlations and Working Group in Interventional Neuroradiology (ABC-WIN) Seminar in Val d’Isere, France.

EndoVantage Reaches Final Round in Venture Madness Competition
March, 2015
EndoVantage earns second place in the Venture Madness Competition, receiving a $10,000 cash prize. Read more.

EndoVantage Wins Prestigious Arizona Award
January, 2015
EndoVantage receives the Flinn Entrepreneurship Award, including a $30,000 cash prize

EndoVantage CSO Wins Prestigious Awards
November, 2014
EndoVantage CSO David Frakes, Ph.D. receives the World Technology Award in the Health & Medicine category from the World Technology Network, as well as the Arizona Governor’s Celebration of Innovation Award in the Academia category. Read more.

EndoVantage CEO Discusses the Growth of the Biotech Industry in Arizona
October 2, 2014 , InBusiness
EndoVantage CEO Robert Green discusses the growth and advancement of the biotech industry in Arizona. Read more.

EndoVantage Wins Prestigious International Award
October 2, 2014.
EndoVantage has won the 2014 Mimics Innovation Award in the poster category for the North and South American region. Read more.
Winning Poster

ASU Spinout Promises Global Market Impact
July 16, 2014, ASU News
Medical device modeling software sparks tech startup. Read more.

Dr. Chong Presents the EndoVantage Technology at the SNIS Conference
July 7, 2014
Chong B, Babiker H, Frakes D, Ryan J, Gonzalez F. E-061 Towards the Pre-Surgical Treatment Planning of Cerebral Aneurysms Using High Fidelity Simulations. Society of NeuroInterventional Surgery. Read more.

EndoVantage Wins the Arizona Innovation Challenge
June 25, 2014, ACA Press Release
EndoVantage wins the Arizona Commerce Authority’s Spring 2014 Arizona Innovation Challenge (AIC) and receives a prize of $250,000. Read more.

EndoVantage Accepted into ASU Edson Entrepreneurial Program.
May, 2014
EndoVantage is accepted into the ASU Edson Entrepreneurial Program, including a $20,000 award.

EndoVantage in Final Round of Venture Madness Competition
February 25, 2014. AZ Tech Beat
EndoVantage has survived two online elimination rounds, reducing the participating companies from 64 to 16, and is now set for the final round of oral presentations to be held March 5-7 at Talking Stick Resort in Scottsdale, Arizona. At stake is a share of $50,000 in cash prizes. Read more.

EndoVantage Accepted In Softlayer Startup Incubator
February 19, 2014,
Softlayer, an IBM company, has accepted EndoVantage in its startup incubator. As a participant, EndoVantage will receive mentoring by Softlayer’s Innovation Team, marketing and other business assistance.

EndoVantage Collaborating with IBM; joins IBM PartnerWorld
February 14 2014.
EndoVantage is now collaborating with IBM on its cloud and super-computing needs and has joined IBM PartnerWorld, providing EndoVantage a broad range of resources to build and implement solutions based on IBM products and services.

Roszelle et al. publish scientific work using the EndoVantage technology
February 5, 2014.
Roszelle B, Nair P, Gonzalez L, Babiker H, Ryan J, and Frakes D. Comparison Among Different High Porosity Stent Configurations: Hemodynamic Effects of Treatment in a Large Cerebral Aneurysm. Journal of Biomechanical Engineering. Read more.

Babiker et al. Publish Scientific Work using the EndoVantage Technology
November 15, 2013.
Babiker M, Chong, B, Gonzalez L, Cheema S, Frakes D. Finite Element Modeling of Embolic Coil Deployment: Multifactor Characterization of Treatment Effects on Cerebral Aneurysm Hemodynamics. Journal of Biomechanics. Read more.

EndoVantage Inducted into Great Little Companies Network
September 5, 2013.
EndoVantage was selected to join ASU’s Great Little Companies Network, entitling it to $3,000 in grant funding, entrance into ASU’s various start-up training programs, use of special collaboration spaces and access to ASU mentors.

EndoVantage Founders receive Mayo Clinic/ASU Commercialization Award
March 29, 2013, ASU News
The Mayo Clinic Center for Individualized Medicine and Arizona State University have awarded EndoVantage founders David Frakes, Ph.D. and Brian Chong, M.D., a Commercialization in Individualized Medicine Award in the amount of $100,000. The award will be used to continue the development and commercialization of the EndoVantage technology. Read more.

Early EndoVantage Technology Featured on NeuroNews
October 2, 2012.
Foundational work on the EndoVantage technology is featured on the front page of NeuroNews.

EndoVantage CSO Receives Prestigious Award 
February, 2012
EndoVantage CSO David Frakes, Ph.D. receives the NSF CAREER Award during early stage development of the EndoVantage Technology. This includes a total cash reward of $429,000. Read more.

Early EndoVantage Technology Receives Significant Funding from Prestigious Grant
December, 2011
Foundational work on the EndoVantage technology receives $40,000 from the ASU-Mayo Seed Grant.

Early EndoVantage Technology Receives Significant Funding from Prestigious Grant
July, 2011
Foundational work on the EndoVantage technology receives $132,000 from the American Heart Association Grant.

Early EndoVantage Technology Receives Significant Funding from Prestigious Grants
October, 2010
Foundational work on the EndoVantage technology receives $25,000 from the Brain Aneursym Foundation Research Grant and $50,000 from the Women and Philanthropy Society Grant.